{
    "title": "Boost for Astrazeneca and Glaxosmithkline: Drug giants to be at heart of post-Brexit UK",
    "url": "https://www.dailymail.co.uk/money/markets/article-9076515/Drug-giants-heart-post-Brexit-UK.html",
    "date": "2020-12-21",
    "keywords": [
        "drug",
        "life",
        "coronavirus",
        "share",
        "fund",
        "approval",
        "sector",
        "year",
        "prowess",
        "display",
        "boost",
        "astra",
        "pharma",
        "uk",
        "treatment",
        "tumour",
        "risk",
        "investment",
        "account",
        "fee",
        "heart",
        "postbrexit",
        "economy",
        "vocabria",
        "number",
        "light",
        "europe",
        "time",
        "astrazeneca",
        "tagrisso",
        "lung",
        "cancer",
        "crisisthe",
        "work",
        "covid19",
        "regulator",
        "quicker",
        "case",
        "jab",
        "pfizer",
        "basis",
        "process",
        "crisis",
        "vaccine",
        "oxford",
        "university",
        "end",
        "review",
        "healthcare",
        "agency",
        "mhra",
        "speed",
        "approach",
        "glaxosmithkline",
        "spending",
        "soriot",
        "rival",
        "brummer",
        "giant",
        "article",
        "place",
        "brexit",
        "transition",
        "source",
        "world",
        "glaxo",
        "hiv",
        "shot",
        "frequency",
        "medication",
        "mutation",
        "death",
        "cent",
        "diy",
        "capital",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}